Infertility. Supervision of high-risk pregnancy
Conditions
Interventions
Intervention 1: Case Group: Progestrone, Vaginal 400 mg daily, For 10 days starting from the day after Intrauterine insemination. Intervention 2: Control Group: Drug or placebo did not use.
Treatment - Drugs
Case Group: Progestrone, Vaginal 400 mg daily, For 10 days starting from the day after Intrauterine insemination
Control Group: Drug or placebo did not use.
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Infertile Couples; Infertility with male factor; Cervical factor; Other unexplained cases Exclusion criteria: Women over 40 years old; Patients with more than two times Intrauterine insemination failure; Woman with baseline FSH more than 12 IU/Lit
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy Rate. Timepoint: 21th to 30th days after Intra Uterine Insemination. Method of measurement: sonography.;Pregnancy Rate. Timepoint: 14th or 17th days after Intra Uterine Insemination. Method of measurement: Blood Beta HCG. | — |
Secondary
| Measure | Time frame |
|---|---|
| Luteal phase period. Timepoint: 2 weeks after IUI. Method of measurement: questionerer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Shahnaz Aali
Kerman University of Medical Sciences
Outcome results
None listed